Is SunOpta, Inc. overvalued or undervalued?

As of 21 November 2025, the valuation grade for SunOpta, Inc. has moved from attractive to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued, with a P/E ratio of 81, a Price to Book Value of 3.94, and an EV to EBITDA of 12.92. In comparison, peers like John B. Sanfilippo & Son, Inc. exhibit a much lower P/E of 12.73 and an EV to EBITDA of 7.10, highlighting the disparity in valuation metrics within the industry.
Additionally, SunOpta's recent stock performance has been significantly underwhelming, with a year-to-date return of -56.49% compared to a positive 12.26% return for the S&P 500, further reinforcing the notion of overvaluation. The company's ROCE stands at 7.97% and ROE at 4.87%, which are relatively low compared to industry expectations, suggesting that the current valuation may not be justified by its financial performance.